PIROXICAM TEVA 20 mg/1 ml, solution for injection (IM) 2 ampoules of 1 ml
Active ingredients: Piroxicam
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection2 ampoules of 1 mlintramusculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PIROXICAM TEVA 20 mg/1 ml, solution injectable (IM)
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire
- Presentation description
- 2 ampoule(s) en verre jaune(brun) de 1 ml
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- 15%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 29 Sept 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69721369CIP73611537CIP133400936115378Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PIROXICAMsolution | 20 mg · une ampoule de 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.